Precigen (PGEN) Net Margin Growth (1y) (2013 - 2026)

Precigen (PGEN) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 400,415.00

Historic Data

Download Data
DateValue
Mar 31, 2026 400,415.00
Dec 31, 2025 23,581.00
Sep 30, 2025 236.33 Mn
Jun 30, 2025 478,845.00
Mar 31, 2025 -180,933.00
Sep 30, 2022 75,313.00
Jun 30, 2022 396.00
Mar 31, 2022 6,583.00
Dec 31, 2021 -974.00
Sep 30, 2021 -9,500.00
Jun 30, 2021 37,629.00
Mar 31, 2021 13,627.00
Dec 31, 2020 77,631.00
Sep 30, 2020 1,667.00
Jun 30, 2020 -7,069.00
Mar 31, 2020 -7,692.00
Dec 31, 2019 -27,934.00
Sep 30, 2019 17,043.00
Jun 30, 2019 13,607.00
Mar 31, 2019 8,669.00